Nerac

Information That Drives Innovation

We’re here to help with your research needs
+1 860 872 7000
Customer Access
  • Home
  • What We Do
    • Nerac IPDex™
    • Innovation Insights and Consulting Practice
    • Regulatory
    • Medical Device and Life Sciences
    • Technology Scouting and Innovation
    • Market Research
    • Intellectual Property
    • Commercialization Services for TTOs and Start-Ups
    • Critical Updates
  • Who We Serve
  • How to Engage
  • Why Nerac?
  • Meet our Team
    • Leadership Team
    • Our Analysts
    • Our Partners
  • Nerac Insights and Publications
    • Articles
    • Case Studies
    • Press Room
    • Videos
    • Webcasts
    • White Papers
  • Contact Us
You are here: Home / Nerac Insights / White Papers & Reports / Bringing Functional Foods to Market: FDA’s Regulatory Mandate Drives the Process

Bringing Functional Foods to Market: FDA’s Regulatory Mandate Drives the Process

Facebook0
Google+0
LinkedIn0
Twitter0

Originally published February, 2011

Introduction

Bringing a new functional food product to market is a potentially complex process with many decision points driven by the US Food and Drug Administration’s (FDA) regulatory mandate. There is no single definition for functional foods, also known as nutraceuticals. They may encompass a range of products and uses, including dietary supplements, medical foods food additives or drugs. Careful consideration of the potential market for a product must be weighed against the time and expense necessary to determine the exact status of a product under the laws and regulations administered by the FDA. The regulatory status of a product is quite often the basis for the marketing of that product, so every possible consideration should be given to assure scientifically sound and legally defensible claims made for the functionality of the product.

This report outlines the requirements for each potential option and the relevant advantages and drawbacks of each pathway. It is intended to provide valuable background information on regulatory compliance, specific types of claims and key product categories.

Read The Full White Paper Here!

Related Posts

  • FDA’s Proposed Regulatory Changes to Laboratory-Developed Tests (LDTs)
    50
    By Roz Sweeney, Ph.D., Nerac Analyst Originally Published: November 17th, 2014 Introduction The FDA recently issued updated draft guidance for proposed regulatory changes affecting laboratory developed tests (LDTs). Laboratory developed tests (or LDTs) are traditionally IVDs developed and used by CLIA labs for treating or testing patients within that lab’s associated healthcare facility. They have…
    Tags: fda, regulatory, published, originally, read
  • Nutraceutical IP and Regulatory Claims
    47
    Originally published September, 2008 Food makers increasingly rely on patented technologies to improve functionality, but strict regulations hamper marketing benefits. The United States functional foods market is relatively immature compared to that of nutraceuticals. From an intellectual property standpoint, this may be because functional food technology develops from within the food industry, while nutraceuticals may…
    Tags: food, functional, read, fda, foods, originally, claims, published
  • Market Analysis - Food Manufacturing
    45
    Issue: The Director of R&D at a world-wide manufacturing company was deciding whether to acquire the rights to distribute a coating nanotechnology process for food contact surfaces. The company enlisted Nerac’s help to vet the technology and the potential market opportunities. Analyst Approach: The Nerac team compared the nanotechnology process in question to other similar…
    Tags: process, market, food, potential, read, regulatory
  • Case Studies
  • White Papers
  • Webcasts
  • Articles
    • Nerac Strategist
    • Energy
    • Food & Nutrition
    • Intellectual Property
    • Regulatory
    • Technology & Innovation
    • Medical Device & Healthcare
    • Pharmaceutical
    • Engineering
    • Market Research
    • Critical Alerts
    • Chemistry/Advanced Materials
  • Press Room

Click here to learn more about….

3d printing advanced materials aerospace Ask Kevin Videos biotech CFDA clinical literature evaluations commercialization strategies competitive intelligence Disruptive Technologies emerging markets energy EU MDR FDA food helga weires Industry 4.0 innovation Inspiring Next intellectual property intellectual property strategies IP market analysis market research medical device medical devices nerac Nerac client questions Nerac Strategist notified body audit open innovation Order 650 patenting strategies patent landscape pharmaceutical Post-Market Surveillance R&D regulatory regulatory compliance Robert Beinstein Rosemarie Szostak specialty chemicals Sustainable Development Goals technology scouting XcellR8
  • Facebook
  • Google+
  • LinkedIn
  • RSS
  • Twitter
  • YouTube
  • Career Opportunities
  • Privacy Policy

Copyright © 2023 Nerac · One Technology Drive · Tolland, CT 06084 · 1.860.872.7000

Sign Up for the Nerac Strategist

Like what you see? Sign up here to receive the Nerac Strategist newsletter, a compilation of analyst insights on rapidly developing industry issues, compliance challenges and commercial opportunities!
  • This field is for validation purposes and should be left unchanged.